Tenet Healthcare Corp THC

FY2025 · ended Dec 31, 2025 · Revenue $21.31B, +3.1% YoY · Filed Feb 17, 2026

Tenet Healthcare Corp (THC) files with the SEC under industry code 8062, Services-General Medical & Surgical Hospitals, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $21.3 billion and net income of $2.4 billion. Free cash flow was $2.5 billion. As of Sep 30, 2026 it held $2.7 billion in cash and investments and $13.2 billion in total debt.

Revenue (TTM)
$22.15B
+6.2% vs year-ago TTM
Net income (TTM)
$3.81B
+66.2% vs year-ago TTM
Operating cash flow (TTM)
$4.24B
+71.0% vs year-ago TTM
Free cash flow (TTM)
$3.33B
+121.6% vs year-ago TTM
EPS (TTM)
$34.09
+133.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
86.96M
-8.6% vs prior year
Net cash
$-10.57B
as of Sep 30, 2026
Operating margin
24.4%
FY 2026

Company profile

Industry
Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
Listed as
THC (NYSE)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Dallas, TX
SEC filer status
Large accelerated filer
SEC CIK
70318
Former names
NATIONAL MEDICAL ENTERPRISES INC /NV/ (until Mar 27, 1995)

Other Services-General Medical & Surgical Hospitals, NEC companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$21.3B
$20.7B
$20.6B
$19.2B
$19.5B
Operating income
$3.5B
$6.0B
$2.5B
$2.3B
$2.9B
Net income
$2.4B
$4.1B
$1.3B
$1.0B
$1.5B
Diluted EPS
$15.49
$32.70
$5.71
$3.79
$8.42
Operating cash flow
$3.5B
$2.0B
$2.4B
$1.1B
$1.6B
Free cash flow
$2.5B
$1.1B
$1.6B
$321.0M
$910.0M
Total assets
$29.7B
$28.9B
$28.3B
$27.2B
$27.6B
Total liabilities
$20.7B
$20.4B
$22.8B
$22.5B
$23.3B
Stockholders' equity
$4.2B
$4.2B
$1.6B
$1.1B
$1.0B
Cash and investments
$2.9B
$3.1B
$1.3B
$888.0M
$2.4B
Total debt
$14.4B
$14.3B
$16.2B
$16.3B
$16.8B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Material agreement, New debt
Sep 22, 2026 Sep 22, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2026 Sep 8, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 23, 2026 Jul 23, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.